Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 4063865, 12 pages
https://doi.org/10.1155/2017/4063865
Research Article

Curcumin Induces p53-Null Hepatoma Cell Line Hep3B Apoptosis through the AKT-PTEN-FOXO4 Pathway

1Department of Microbiology, Soochow University, Shihlin, Taipei 111, Taiwan
2Department of Medical Research, Taipei Veterans General Hospital, Taipei 112, Taiwan

Correspondence should be addressed to Chu-Wen Yang; wt.ude.ucs@1686wcy

Received 25 February 2017; Accepted 6 June 2017; Published 9 July 2017

Academic Editor: Jae Youl Cho

Copyright © 2017 An-Ting Liou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. X. Zhu, W.-K. Seto, C.-L. Lai, and M.-F. Yuen, “Epidemiology of hepatocellular carcinoma in the Asia-Pacific region,” Gut and Liver, vol. 10, no. 3, pp. 332–339, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. K. A. McGlynn and W. T. London, “The global epidemiology of hepatocellular carcinoma: present and future,” Clinics in Liver Disease, vol. 15, no. 2, pp. 223–243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2016,” CA: A Cancer Journal for Clinicians, vol. 66, no. 1, pp. 7–30, 2016. View at Publisher · View at Google Scholar
  4. B. C. Lewis, D. S. Klimstra, N. D. Socci, S. Xu, J. A. Koutcher, and H. E. Varmus, “The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma,” Molecular and Cellular Biology, vol. 25, no. 4, pp. 1228–1237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. I. F. Shariff, I. J. Cox, A. I. Gomaa, S. A. Khan, W. Gedroyc, and S. D. Taylor-Robinson, “Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics,” Expert Review of Gastroenterology and Hepatology, vol. 3, no. 4, pp. 353–367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. S. C. Gupta, S. Patchva, W. Koh, and B. B. Aggarwal, “Discovery of curcumin, a component of golden spice, and its miraculous biological activities,” Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 3, pp. 283–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Pulido-Moran, J. Moreno-Fernandez, C. Ramirez-Tortosa, and M. Ramirez-Tortosa, “Curcumin and health,” Molecules, vol. 21, no. 3, p. E264, 2016. View at Publisher · View at Google Scholar
  8. R. Kotecha, A. Takami, and J. L. Espinoza, “Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence,” Oncotarget, vol. 7, no. 32, pp. 52517–52529, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. G. B. Maru, R. R. Hudlikar, G. Kumar, K. Gandhi, and M. B. Mahimkar, “Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trials,” World Journal of Biological Chemistry, vol. 7, no. 1, pp. 88–99, 2016. View at Google Scholar
  10. D. Bandyopadhyay, “Farmer to pharmacist: Curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer,” Frontiers in Chemistry, vol. 2, article no. 113, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. A. R. Pavan, G. D. B. da Silva, D. H. Jornada et al., “Unraveling the anticancer effect of curcumin and resveratrol,” Nutrients, vol. 8, no. 11, p. E628, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Vyas, P. Dandawate, S. Padhye, A. Ahmad, and F. Sarkar, “Perspectives on new synthetic curcumin analogs and their potential anticancer properties,” Current Pharmaceutical Design, vol. 19, no. 11, pp. 2047–2069, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Ravindran, S. Prasad, and B. B. Aggarwal, “Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?” AAPS Journal, vol. 11, no. 3, pp. 495–510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M.-C. Jiang, H.-F. Yang-Yen, J.-K. Lin, and J. J.-Y. Yen, “Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells,” Oncogene, vol. 13, no. 3, pp. 609–616, 1996. View at Google Scholar · View at Scopus
  15. K. S. Bhullar, A. Jha, and H. P. V. Rupasinghe, “Novel carbocyclic curcumin analog CUR3d modulates genes involved in multiple apoptosis pathways in human hepatocellular carcinoma cells,” Chemico-Biological Interactions, vol. 242, pp. 107–122, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Chen, L. Li, J. Su, and T. Chen, “Natural borneol enhances bisdemethoxycurcumin-induced cell cycle arrest in the G2/M phase through up-regulation of intracellular ROS in HepG2 cells,” Food and Function, vol. 6, no. 3, pp. 740–748, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Guan, Y. Ding, Y. Zhang, Y. Zhou, M. Li, and C. Wang, “Curcumin suppresses proliferation and migration of MDA-MB-231 breast cancer cells through autophagy-dependent Akt degradation,” PLoS ONE, vol. 11, no. 1, Article ID e0146553, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Jin, F. Qiao, Y. Wang, Y. Xu, and Y. Shang, “Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway,” Oncology Reports, vol. 34, no. 5, pp. 2782–2789, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Rana, H. Piplani, V. Vaish, B. Nehru, and S. N. Sanyal, “Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer,” Molecular and Cellular Biochemistry, vol. 402, no. 1-2, pp. 225–241, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Zhang, W. Xu, B. Li et al., “Curcumin Promotes Cell Cycle Arrest and Inhibits Survival of Human Renal Cancer Cells by Negative Modulation of the PI3K/AKT Signaling Pathway,” Cell Biochemistry and Biophysics, vol. 73, no. 3, pp. 681–686, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Yu, Y. Wan, Y. Liu, J. Yang, L. Li, and W. Zhang, “Curcumin induced apoptosis via PI3K/Akt-signalling pathways in SKOV3 cells,” Pharmaceutical Biology, vol. 54, no. 10, pp. 2026–2032, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Zhao, C. Li, H. Xi, Y. Gao, and D. Xu, “Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway,” Molecular Medicine Reports, vol. 12, no. 4, pp. 5415–5422, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Angulo, G. Kaushik, D. Subramaniam et al., “Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy,” Journal of Hematology Oncology, vol. 10, no. 1, p. 10, 2017. View at Publisher · View at Google Scholar
  24. A. R. Hussain, M. Al-Rasheed, P. S. Manogaran et al., “Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in acute T cell leukemias,” Apoptosis, vol. 11, no. 2, pp. 245–254, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Chiablaem, K. Lirdprapamongkol, S. Keeratichamroen, R. Surarit, and J. Svasti, “Curcumin suppresses vasculogenic mimicry capacity of hepatocellular carcinoma cells through STAT3 and PI3K/AKT inhibition,” Anticancer Research, vol. 34, no. 4, pp. 1857–1864, 2014. View at Google Scholar · View at Scopus
  26. H. Yang, R. Zhao, H.-Y. Yang, and M.-H. Lee, “Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity,” Oncogene, vol. 24, no. 11, pp. 1924–1935, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Zhang, C. Wan, W. Shi et al., “The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs,” Journal of Molecular Histology, vol. 46, no. 6, pp. 485–497, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Xie, J. Li, J. Chen, X. Tang, S. Wu, and C. Liao, “Knockdown of flotillin-2 impairs the proliferation of breast cancer cells through modulation of Akt/FOXO signaling,” Oncology Reports, vol. 33, no. 5, pp. 2285–2290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. S. K. Roy, R. K. Srivastava, and S. Shankar, “Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer,” Journal of Molecular Signaling, vol. 5, p. 10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Chen, Y. Tang, J. Wang, Z. Yan, and R. Xu, “MiR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4,” Biochemical and Biophysical Research Communications, vol. 435, no. 4, pp. 745–750, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Li, L. Hu, C. Tian, F. Lu, J. Wu, and L. Liu, “microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4,” BMC Molecular Biology, vol. 16, no. 1, article no. 24, 2015. View at Publisher · View at Google Scholar · View at Scopus